O Que Fazemos
O nosso aconselhamento estratégico ajuda a concretizar as ideias operacionais e organizacionais dos nossos clientes.
Concentramo-nos na criação de mudanças positivas no sector da saúde e, com os atuais peritos em saúde, criámos uma comunidade para partilhar e moldar ideias que transformarão os cuidados de saúde.
Trabalhamos para assegurar a transformação do sector, gerando um impacto significativo sobre os clientes, fornecendo conhecimentos estratégicos e criando um sistema de saúde que satisfaça as necessidades das comunidades e das empresas.
A 1 de Novembro de 2021, a equipa de consultoria estratégica de Saúde e Ciências da Vida da Huron juntou-se a Oliver Wyman, permitindo-nos levar a nossa busca por uma forma mais otimizada de operar a empresas farmacêuticas, biotecnológicas e de dispositivos médicos. Os nossos novos colegas trazem a perícia necessária para ajudar as empresas de saúde a abordar as suas questões estratégicas mais prementes, incluindo questões de marketing e de acesso cada vez mais complexas.
Como pensamos
Designing For 2035
Dive into the future of healthcare with industry leaders. Discover innovative strategies for designing a healthcare system for the next decade
Saiba maisThe Impact Of Climate Change On Human Health
This new study projects as many as 14.5 million additional deaths and $12.5 trillion in economic losses by 2050
Saiba maisLife sciences Dealmaking Poised To Rebound In 2024
Investors should be encouraged by the increased need for new revenue streams and heightened demand for inorganic growth strategies among biopharma companies
Saiba maisEurope's Innovation Dilemma
Europe’s pharmaceutical industry risks falling behind the rest of the world without increased investment in innovation
Saiba maisHow Pharma Can Achieve Net Zero Goals
Pharmaceutical companies are making bold pledges to reduce their carbon footprints. Getting there means overcoming some significant hurdles
Saiba maisThe Case For Partnering With Your Competitors
From a potential recession to growing cost pressures, insurers face a host of uncertainties this year. One way to ease the pain is to take a cue from other industries and partner with competitors.
Saiba maisA Personalized Model For Primary Care
Primary care must evolve to better meet patient needs and improve the patient experience.
Saiba maisClosing The Gender Health Gap
Pharma’s opportunity to move the needle on closing the gender health gap.
Saiba maisSoluções
There is immense pressure across the entire healthcare landscape to provide higher quality care, improve the patient experience, lower costs, and reduce clinician burnout. Our Affordability and Quality Impact practice has deep expertise across lines of business to help organizations identify cost drivers, find efficiencies, improve quality of care, and more.
O nosso modelo ajuda os decisores políticos a compreender o impacto das elevadas taxas de desemprego na futura combinação de seguros de saúde.
Quem Somos
-
Deirdre Baggot Partner and Private Capital Leader
-
Andreas Eggert Partner, Europe Health and Life Sciences Leader
-
Martin Graf Partner and Government Services Leader
-
Minoo Javanmardian Partner and Provider Transformation Leader
-
Adeel Kheiri Partner
-
Ben Paik Partner and Americas Life Sciences Leader
-
Shivani Shah Executive Director and Health Innovation Center Leader
-
Sumit Sharma Partner and Head of Health and Life Sciences, IMEA
-
Terry Stone Managing Partner